These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
323 related articles for article (PubMed ID: 16980204)
101. Initial work-up and long-term follow-up in patients with phaeochromocytomas and paragangliomas. Plouin PF; Gimenez-Roqueplo AP Best Pract Res Clin Endocrinol Metab; 2006 Sep; 20(3):421-34. PubMed ID: 16980203 [TBL] [Abstract][Full Text] [Related]
102. [Some etiopathogenetic and diagnostic considerations in neuroendocrine tumors, with particular attention to those in urology]. Alberti C Recenti Prog Med; 2011 Jun; 102(6):267-77. PubMed ID: 21779109 [TBL] [Abstract][Full Text] [Related]
103. Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma. Amar L; Servais A; Gimenez-Roqueplo AP; Zinzindohoue F; Chatellier G; Plouin PF J Clin Endocrinol Metab; 2005 Apr; 90(4):2110-6. PubMed ID: 15644401 [TBL] [Abstract][Full Text] [Related]
105. Pheochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care center. Pham TH; Moir C; Thompson GB; Zarroug AE; Hamner CE; Farley D; van Heerden J; Lteif AN; Young WF Pediatrics; 2006 Sep; 118(3):1109-17. PubMed ID: 16951005 [TBL] [Abstract][Full Text] [Related]
106. Pheochromocytoma: When to search a germline defect? Buffet A; Burnichon N; Amar L; Gimenez-Roqueplo AP Presse Med; 2018; 47(7-8 Pt 2):e109-e118. PubMed ID: 30100270 [TBL] [Abstract][Full Text] [Related]
107. [Achievements of the COMETE program in the genetics of pheochromocytoma]. Gimenez-Roqueplo AP; Burnichon N; Amar L; Favier J; Jeunemaitre X; Plouin PF Bull Acad Natl Med; 2008 Jan; 192(1):105-15; discussion 115-6. PubMed ID: 18663985 [TBL] [Abstract][Full Text] [Related]
108. [Pheochromocytoma and paraganglioma]. Gimenez-Roqueplo AP Rev Prat; 2015 Jun; 65(6):826-30. PubMed ID: 26298909 [TBL] [Abstract][Full Text] [Related]
112. Precision medicine in pheochromocytoma and paraganglioma: current and future concepts. Björklund P; Pacak K; Crona J J Intern Med; 2016 Dec; 280(6):559-573. PubMed ID: 27165774 [TBL] [Abstract][Full Text] [Related]
113. [Novel methods and their applicability in the evaluation of the genetic background of endocrine system tumours]. Patócs A; Likó I; Butz H; Baghy K; Rácz K Orv Hetil; 2015 Dec; 156(51):2063-9. PubMed ID: 26654542 [TBL] [Abstract][Full Text] [Related]
114. [Genetics of neuroendocrine tumors]. Calender A Rev Prat; 2002 Feb; 52(3):256-61. PubMed ID: 11925714 [TBL] [Abstract][Full Text] [Related]
115. High prevalence of SDHB mutations in head and neck paraganglioma in Belgium. Persu A; Hamoir M; Grégoire V; Garin P; Duvivier E; Reychler H; Chantrain G; Mortier G; Mourad M; Maiter D; Vikkula M J Hypertens; 2008 Jul; 26(7):1395-401. PubMed ID: 18551016 [TBL] [Abstract][Full Text] [Related]
116. Phaeochromocytoma and paraganglioma: next-generation sequencing and evolving Mendelian syndromes. Maher ER Clin Med (Lond); 2014 Aug; 14(4):440-4. PubMed ID: 25099851 [No Abstract] [Full Text] [Related]
117. Germline mutations in PTEN and SDHC in a woman with epithelial thyroid cancer and carotid paraganglioma. Zbuk KM; Patocs A; Shealy A; Sylvester H; Miesfeldt S; Eng C Nat Clin Pract Oncol; 2007 Oct; 4(10):608-12. PubMed ID: 17898811 [TBL] [Abstract][Full Text] [Related]